Previous Close | 35.21 |
Open | 35.11 |
Bid | 35.04 x 0 |
Ask | 35.05 x 0 |
Day's Range | 34.89 - 35.24 |
52 Week Range | 27.99 - 41.50 |
Volume | |
Avg. Volume | 2,294,249 |
Market Cap | 32.613B |
Beta (5Y Monthly) | 0.80 |
PE Ratio (TTM) | 11.05 |
EPS (TTM) | 3.17 |
Earnings Date | Feb 07, 2023 - Feb 13, 2023 |
Forward Dividend & Yield | 1.96 (6.47%) |
Ex-Dividend Date | Aug 31, 2022 |
1y Target Est | 34.11 |
Great-West Lifeco Inc. (the "Corporation") announced today that it has received approval from the Toronto Stock Exchange ("TSX") for the renewal of its Normal Course Issuer Bid ("NCIB").
Great-West Lifeco Inc. ("Lifeco") has been notified of an unsolicited mini-tender offer by Obatan LLC, made to residents of Ireland, to purchase up to 50,000 common shares of Lifeco. The unsolicited offer represents a discount of approximately 31.1% to the closing price of the common shares on the TSX on December 29, 2022, the last trading day before the offer was commenced. The common shares do not trade on a recognized stock exchange in Ireland.
Great-West Lifeco Inc. is pleased to announce the appointment of Dervla Tomlin, current Chief Actuary, as Chief Risk Officer, effective February 13, 2023.